Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMAR
1101
DELISTED
Smartsheet Inc.
SMAR
| $2.76M | ﹤0.01% |
57,701
+34,047
| +144% | +$1.48M |
|
1102
Northern Trust
NTRS
$35B
| $2.75M | ﹤0.01% |
31,188
+5,760
| +23% | +$534K |
|
1103
Corcept Therapeutics
CORT
$12.1B
| $2.72M | ﹤0.01% |
125,800
-17,015
| -12% | -$373K |
|
1104
GameStop
GME
$8.32B
| $2.72M | ﹤0.01% |
118,112
+69,328
| +142% | +$1.38M |
|
1105
PVH
PVH
$3.76B
| $2.72M | ﹤0.01% |
30,490
+17,277
| +131% | +$1.41M |
|
1106
Norwegian Cruise Line
NCLH
$8.69B
| $2.72M | ﹤0.01% |
201,986
+113,498
| +128% | +$1.7M |
|
1107
Principal Financial Group
PFG
$24.4B
| $2.7M | ﹤0.01% |
36,398
+7,326
| +25% | +$622K |
|
1108
KeyCorp
KEY
$24.5B
| $2.7M | ﹤0.01% |
215,872
+112,772
| +109% | +$1.9M |
|
1109
Bloom Energy
BE
$69.9B
| $2.7M | ﹤0.01% |
135,483
+41,391
| +44% | +$906K |
|
1110
Agnico Eagle Mines
AEM
$93.8B
| $2.7M | ﹤0.01% |
53,035
-43,727
| -45% | -$2.25M |
|
1111
Wyndham Hotels & Resorts
WH
$5.49B
| $2.7M | ﹤0.01% |
39,755
+21,611
| +119% | +$1.59M |
|
1112
Exelixis
EXEL
$12.5B
| $2.68M | ﹤0.01% |
137,987
-73,456
| -35% | -$1.28M |
|
|
UNVR
1113
DELISTED
Univar Solutions Inc.
UNVR
| $2.68M | ﹤0.01% |
76,487
+44,431
| +139% | +$1.51M |
|
1114
Tyson Foods
TSN
$19.6B
| $2.67M | ﹤0.01% |
45,002
-89,134
| -66% | -$5.47M |
|
1115
Asbury Automotive
ABG
$3.76B
| $2.66M | ﹤0.01% |
12,688
+4,142
| +48% | +$878K |
|
1116
TechnipFMC
FTI
$29.5B
| $2.66M | ﹤0.01% |
194,936
+110,933
| +132% | +$1.5M |
|
1117
Hyatt Hotels
H
$16.8B
| $2.64M | ﹤0.01% |
23,629
+11,976
| +103% | +$1.31M |
|
|
CIVI
1118
DELISTED
Civitas Resources
CIVI
| $2.64M | ﹤0.01% |
38,651
+27,404
| +244% | +$1.78M |
|
1119
Hexcel
HXL
$7.74B
| $2.63M | ﹤0.01% |
38,598
+21,838
| +130% | +$1.48M |
|
1120
Shoals Technologies Group
SHLS
$1.4B
| $2.63M | ﹤0.01% |
115,463
+71,751
| +164% | +$1.77M |
|
1121
Saic
SAIC
$5.34B
| $2.63M | ﹤0.01% |
24,445
+13,339
| +120% | +$1.41M |
|
1122
Houlihan Lokey
HLI
$8.63B
| $2.62M | ﹤0.01% |
29,934
+15,040
| +101% | +$1.42M |
|
1123
Murphy USA
MUSA
$10.1B
| $2.61M | ﹤0.01% |
10,133
+6,443
| +175% | +$1.68M |
|
1124
Synchrony
SYF
$25.8B
| $2.61M | ﹤0.01% |
89,593
+11,292
| +14% | +$379K |
|
1125
H&R Block
HRB
$6.87B
| $2.6M | ﹤0.01% |
73,706
+41,892
| +132% | +$1.55M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.